Valuation: Isodiol International Inc

Market Cap 3.91M 2.75M 2.44M 2.28M 2.07M 265M 3.94M 27.44M 10.67M 135M 10.32M 10.1M 435M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.42M 5.7M 5.34M 4.84M 619M 9.2M 64.08M 24.92M 316M 24.11M 23.59M 1.02B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
Manager TitleAgeSince
Chief Executive Officer - 24/05/2017
Corporate Officer/Principal - 30/08/2018
Director TitleAgeSince
Director/Board Member - 24/05/2017
Director/Board Member - 30/08/2018
Director/Board Member - 21/11/2018
Change 5-day change 1-year change 3-year change Capi.($)
-90.63%+880.01% - - 128
+1.26%-2.29%+36.97%+104.79% 1,019B
+0.73%-4.78%+35.41%+61.62% 610B
+0.35%+1.29%+15.86%+79.90% 470B
+1.72%-4.92%+59.84%+36.64% 344B
+0.26%+0.14%+21.29%+40.99% 336B
+0.60%-3.09%+10.76%+32.59% 266B
+1.65%-3.78%-6.03%+9.29% 241B
-0.09%-4.97%+36.88%+50.52% 218B
-0.28%-4.66%+26.99%+92.98% 179B
Average -8.72%-3.71%+26.44%+56.59% 409.2B
Weighted average by Cap. +0.05%-3.43%+29.52%+67.02%

Financials

2018 2019
Net sales 19.14M 13.46M 11.95M 11.18M 10.13M 1.3B 19.28M 134M 52.22M 662M 50.52M 49.43M 2.13B 22.25M 15.65M 13.89M 13M 11.78M 1.51B 22.41M 156M 60.71M 769M 58.73M 57.47M 2.47B
Net income -36.02M -25.33M -22.49M -21.04M -19.07M -2.44B -36.28M -253M -98.3M -1.25B -95.08M -93.04M -4B -126M -88.55M -78.6M -73.56M -66.67M -8.54B -127M -883M -344M -4.35B -332M -325M -14B
Net Debt -15.55M -10.93M -9.71M -9.08M -8.23M -1.05B -15.66M -109M -42.43M -538M -41.05M -40.17M -1.73B 5.22M 3.67M 3.26M 3.05M 2.77M 354M 5.26M 36.64M 14.25M 181M 13.78M 13.49M 581M
Logo Isodiol International Inc
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-